What does it mean to have orphan drug status?

By Casey Murphy AAA
A:

In 1982,

The U.S. Food and Drug Administration (FDA) recognized the lack of incentive for pharmaceutical companies to develop cures for rare diseases and established the Office of Orphan Product Development. This branch of the FDA provides incentives to companies that work toward curing rare diseases by exercising the rights given to them under the Orphan Drug Act of January 1983. One type of incentive is the orphan drug status, which provides tax reductions and the exclusive right to develop the cure for a specific condition for a period of seven years to companies attempting to cure rare diseases.

Developing drugs to treat the vast number of diseases in the world is a line of business that can lead to massive fortunes, but unfortunately not all developed drugs become the golden ticket. In the world pharmaceuticals, the largest amount of money can be made by developing drugs that become the standard for curing common diseases.

From a business perspective, having a large market ensures that a company can quickly recuperate the cost of development and can also realize the largest possible gain. For this reason, there is little incentive for pharmaceutical companies to develop cures for rare diseases - those that affect fewer than 200,000 people in the United States - because the small market and high cost associated with finding these types of cures discourages these companies from entering this market.

For related reading, check out Measuring The Medicine Makers.

RELATED FAQS

  1. What does it mean when a company in the drug sector has orphan drugs?

    Understand what it means when a company in the pharmaceutical industry has drugs within its portfolio that are designated ...
  2. In what types of economies are regressive taxes common?

    Understand the three main taxation systems, regressive, proportionate and progressive, and learn where regressive tax systems ...
  3. Is a person registered for Financial Instruments Business eligible to conduct both ...

    Explore Japan's 2006 Financial Instruments and Exchange Law, and understand how the law affects investment services regulation.
  4. Can I stop working to decrease my Substantial Gainful Activity (SGA)?

    Find out how your level of work productivity impacts your ability to earn below the substantial gainful activity (SGA) threshold ...
RELATED TERMS
  1. NEXUS

    A Trusted Traveler Program that allows pre-screened U.S. and ...
  2. Global Entry

    A U.S. program giving pre-approved travelers a faster Customs ...
  3. SENTRI

    This U.S. program grants pre-approved travelers access to a faster ...
  4. Separation Of Powers

    An organizational structure in which responsibilities, authorities, ...
  5. Nordic Model

    The social welfare and economic systems adopted by Nordic countries.
  6. Administrative Order On Consent (AOC)

    An agreement between an individual or business and a regulatory ...

You May Also Like

Related Articles
  1. Investing Basics

    What does it mean when a company in ...

  2. Investing News

    A New Corporate Governance Initiative ...

  3. Economics

    The New Global Banking Regulations To ...

  4. Stock Analysis

    Zynga's New Venture Is A Major Gamble

Trading Center